This bill designates chloroquine, hydroxychloroquine, and ivermectin as over-the-counter drugs, meaning that pharmacists or pharmacies will not be allowed to require a prescription for their purchase. It establishes a new section in the Oklahoma Statutes, specifically Section 353.22.1 of Title 59, which outlines these changes. Additionally, the bill stipulates that if the State Board of Pharmacy finds a pharmacist or pharmacy in violation of this provision, they will face severe penalties, including the immediate revocation of their license and a fine of $100,000 for each occurrence of non-compliance.

The bill is set to take effect on November 1, 2025, providing a timeline for implementation. This legislative change aims to increase access to these specific medications without the barrier of a prescription, while also ensuring accountability for pharmacists and pharmacies that do not adhere to the new regulations.